{"pmid":32347359,"title":"Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.","text":["Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.","Cancer Immunol Immunother","Dong, Haidong","32347359"],"journal":"Cancer Immunol Immunother","authors":["Dong, Haidong"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347359","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s00262-020-02580-1","topics":["Treatment","Prevention"],"weight":1,"_version_":1665441658325434368,"score":8.599203,"similar":[{"pmid":32220710,"pmcid":"PMC7118521","title":"Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2.","text":["Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2.","Med Hypotheses","Roncati, Luca","Gallo, Graziana","Manenti, Antonio","Palmieri, Beniamino","32220710"],"journal":"Med Hypotheses","authors":["Roncati, Luca","Gallo, Graziana","Manenti, Antonio","Palmieri, Beniamino"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32220710","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.mehy.2020.109686","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1664638629681561600,"score":63.519386},{"pmid":32327746,"pmcid":"PMC7178926","title":"Translating IL-6 biology into effective treatments.","text":["Translating IL-6 biology into effective treatments.","In 1973, IL-6 was identified as a soluble factor that is secreted by T cells and is important for antibody production by B cells. Since its discovery more than 40 years ago, the IL-6 pathway has emerged as a pivotal pathway involved in immune regulation in health and dysregulation in many diseases. Targeting of the IL-6 pathway has led to innovative therapeutic approaches for various rheumatic diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis, adult-onset Still's disease, giant cell arteritis and Takayasu arteritis, as well as other conditions such as Castleman disease and cytokine release syndrome. Targeting this pathway has also identified avenues for potential expansion into several other indications, such as uveitis, neuromyelitis optica and, most recently, COVID-19 pneumonia. To mark the tenth anniversary of anti-IL-6 receptor therapy worldwide, we discuss the history of research into IL-6 biology and the development of therapies that target IL-6 signalling, including the successes and challenges and with an emphasis on rheumatic diseases.","Nat Rev Rheumatol","Choy, Ernest H","De Benedetti, Fabrizio","Takeuchi, Tsutomu","Hashizume, Misato","John, Markus R","Kishimoto, Tadamitsu","32327746"],"abstract":["In 1973, IL-6 was identified as a soluble factor that is secreted by T cells and is important for antibody production by B cells. Since its discovery more than 40 years ago, the IL-6 pathway has emerged as a pivotal pathway involved in immune regulation in health and dysregulation in many diseases. Targeting of the IL-6 pathway has led to innovative therapeutic approaches for various rheumatic diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis, adult-onset Still's disease, giant cell arteritis and Takayasu arteritis, as well as other conditions such as Castleman disease and cytokine release syndrome. Targeting this pathway has also identified avenues for potential expansion into several other indications, such as uveitis, neuromyelitis optica and, most recently, COVID-19 pneumonia. To mark the tenth anniversary of anti-IL-6 receptor therapy worldwide, we discuss the history of research into IL-6 biology and the development of therapies that target IL-6 signalling, including the successes and challenges and with an emphasis on rheumatic diseases."],"journal":"Nat Rev Rheumatol","authors":["Choy, Ernest H","De Benedetti, Fabrizio","Takeuchi, Tsutomu","Hashizume, Misato","John, Markus R","Kishimoto, Tadamitsu"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327746","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1038/s41584-020-0419-z","topics":["Treatment"],"weight":1,"_version_":1665420537707364352,"score":60.121754},{"pmid":32266937,"title":"Inside the heart of COVID-19.","text":["Inside the heart of COVID-19.","Cardiovasc Res","Adao, Rui","Guzik, Tomasz J","32266937"],"journal":"Cardiovasc Res","authors":["Adao, Rui","Guzik, Tomasz J"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266937","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cvr/cvaa086","keywords":["cardiovascular system","sars-cov-2","coronavirus","pandemic","angiotensin-converting enzyme 2"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664637636033118208,"score":54.34945},{"pmid":32287788,"pmcid":"PMC7131731","title":"Inside Wuhan's lockdown.","text":["Inside Wuhan's lockdown.","Hubei residents are trying to stay positive as hospitals attempt to treat thousands infected by the new coronavirus, reports Donna Lu.","New Sci","Lu, Donna","32287788"],"abstract":["Hubei residents are trying to stay positive as hospitals attempt to treat thousands infected by the new coronavirus, reports Donna Lu."],"journal":"New Sci","authors":["Lu, Donna"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32287788","week":"202016|Apr 13 - Apr 19","doi":"10.1016/S0262-4079(20)30234-7","source":"PubMed","topics":["General Info"],"weight":1,"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636391704756224,"score":53.926346},{"pmid":32217104,"title":"Inside China and COVID-19: Questions and answers.","text":["Inside China and COVID-19: Questions and answers.","Travel Med Infect Dis","Jiang, Rongmeng","32217104"],"journal":"Travel Med Infect Dis","authors":["Jiang, Rongmeng"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32217104","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.tmaid.2020.101640","source":"PubMed","topics":["Transmission","Diagnosis","Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638742965518339,"score":52.893772}]}